- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02041637
Unknown Cause of Acute Liver Failure (HASIPRO)
May 2, 2017 updated by: Assistance Publique - Hôpitaux de Paris
Unknown Cause of Acute Liver Failure: Determination of Early Mortality Predictive Factors
The purpose of the study is to evaluate the outcome and to determine predictive factors of patients admitted in a context of acute liver failure without identified cause.
Study Overview
Status
Completed
Conditions
Detailed Description
Methodology: Multicentric French national cohort with prospective collection of data and constitution of biobank, in patients hospitalized in a context of acute liver failure without known cause at admission.
Follow-up during 3 months for each patients.
The primary objective is to determine predictive factors of early mortality.
This study is an observational cohort and patients will received standard care during the follow-up.
Study Type
Observational
Enrollment (Actual)
72
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Villejuif, France, 94800
- AP-HP, Paul Brousse Hospital, Centre Hepato-Biliaire
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Acute liver failure without cause identified at admission
Description
Inclusion Criteria:
- Acute liver failure defined by a PT<50% or INR>1.5;
- with or without hepatic encephalopathy;
- without cause identified at admission, and non A non B hepatitis;
- age>18 year old;
- signed an informed consent.
Exclusion Criteria:
- chronic liver disease;
- Patient under guardianship
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
mortality
Time Frame: At 3 months
|
At 3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Liver transplantation rate
Time Frame: At 3 months
|
At 3 months
|
|
Overall survival rate
Time Frame: At 3 months
|
At 3 months
|
|
post-transplant mortality rate
Time Frame: At 3 months
|
At 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Audrey COILLY, MD, Assistance Publique - Hôpitaux de Paris
- Study Director: Didier Samuel, MD, PhD, Assistance Publique - Hôpitaux de Paris
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2013
Primary Completion (Actual)
December 1, 2016
Study Completion (Actual)
January 1, 2017
Study Registration Dates
First Submitted
January 20, 2014
First Submitted That Met QC Criteria
January 20, 2014
First Posted (Estimate)
January 22, 2014
Study Record Updates
Last Update Posted (Actual)
May 3, 2017
Last Update Submitted That Met QC Criteria
May 2, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AOM11030
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Failure
-
Institute of Liver and Biliary Sciences, IndiaCompletedAcute Liver FailureIndia
-
Beijing Continent Pharmaceutical Co, Ltd.RecruitingAcute-On-Chronic Liver Failure | Acute Liver FailureChina
-
Tianjin Weikai Bioeng., Ltd.Tianjin Nankai HospitalUnknownLiver Failure, Acute on ChronicChina
-
Institute of Liver and Biliary Sciences, IndiaCompletedAcute Liver Failure | Acute on Chronic Liver FailureIndia
-
GenfitCompletedAcute-on-Chronic Liver FailureUnited States
-
HLB Cell Co., Ltd.UnknownAcute-On-Chronic Liver Failure | Acute Liver FailureKorea, Republic of
-
Li-Ying SunNot yet recruitingAcute Liver Failure
-
Nanfang Hospital of Southern Medical UniversityCompletedLiver Injury | Liver Failure, Acute on Chronic
-
Institute of Liver and Biliary Sciences, IndiaIndian Council of Medical ResearchNot yet recruiting
-
Institute of Liver and Biliary Sciences, IndiaIndian Council of Medical ResearchNot yet recruiting